Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial PressReach · Oct 27, 2024
The Inner Circle acknowledges, Dr. Andrea Fuyuko Honda as a Pinnacle Professional Member Inner Circle of Excellence PressReach · Oct 26, 2024
Patient Files Civil Suit Against Erlanger Health and Dr. Thomas V. Clayton Alleging Sexual Abuse and Negligence PressReach · Oct 26, 2024
Prime Staffing Defies Industry Trends: Expanding and Hiring Amidst Widespread Healthcare Staffing Layoffs PressReach · Oct 25, 2024
Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC) PressReach · Oct 25, 2024
Brookdale Announces Date of Third Quarter 2024 Earnings Release and Conference Call PressReach · Oct 24, 2024
Oceanfoam Signs Licensing Agreement With Performance Solutions for Its Tidal Rollers PressReach · Oct 24, 2024
101 Mobility Publishes Comprehensive Guide to Stairlifts for Seniors, Addressing Growing Need for Aging-in-Place Solutions PressReach · Oct 24, 2024
